These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 7924634

  • 1. Loss of variability in Graves' disease: stimulatory TSH-receptor antibodies bind to the TSH-receptor in a continued, non-pulsatile and non-chaotic fashion.
    Schuppert F, Diegelmann B, Geest T, Wagner TO, von zur Mühlen A.
    Chronobiologia; 1994; 21(1-2):21-32. PubMed ID: 7924634
    [Abstract] [Full Text] [Related]

  • 2. A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with de novo Graves' disease.
    Hovens GC, Buiting AM, Karperien M, Ballieux BE, van der Pluijm G, Pereira AM, Romijn JA, Smit JW.
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):429-35. PubMed ID: 16584516
    [Abstract] [Full Text] [Related]

  • 3. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.
    Schott M, Minich WB, Willenberg HS, Papewalis C, Seissler J, Feldkamp J, Bergmann A, Scherbaum WA, Morgenthaler NG.
    Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227
    [Abstract] [Full Text] [Related]

  • 4. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
    Takasu N, Kamijo K, Sato Y, Yoshimura H, Nagata A, Ochi Y.
    Clin Exp Pharmacol Physiol; 2004 Dec; 31(5-6):314-9. PubMed ID: 15191404
    [Abstract] [Full Text] [Related]

  • 5. Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment.
    Quadbeck B, Hoermann R, Hahn S, Roggenbuck U, Mann K, Janssen OE.
    Horm Metab Res; 2005 Dec; 37(12):745-50. PubMed ID: 16372228
    [Abstract] [Full Text] [Related]

  • 6. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK, Plicht M, Lax H, Hirche H, Quadbeck B, Mann K, Steuhl KP, Esser J, Morgenthaler NG.
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
    [Abstract] [Full Text] [Related]

  • 7. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H, Kuwert T, Lohmann T.
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [Abstract] [Full Text] [Related]

  • 8. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
    Morgenthaler NG, Ho SC, Minich WB.
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
    [Abstract] [Full Text] [Related]

  • 9. Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study.
    Vos XG, Smit N, Endert E, Tijssen JG, Wiersinga WM.
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):311-7. PubMed ID: 18208575
    [Abstract] [Full Text] [Related]

  • 10. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P, Chiovato L, Fiore E, Mammoli C, Rocchi R, Pinchera A.
    Acta Med Austriaca; 1996 Aug; 23(1-2):52-6. PubMed ID: 8767515
    [Abstract] [Full Text] [Related]

  • 11. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody.
    Ochi Y, Kajita Y, Hamazu M, Nagata A.
    Horm Res; 2003 Aug; 59(5):222-8. PubMed ID: 12714785
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the ratio of T3 release stimulating antibodies to TSH-binding inhibiting antibodies during the course of Graves' disease.
    Hoermann R, Saller B, Mann K.
    Horm Metab Res; 1990 Mar; 22(3):183-7. PubMed ID: 1971613
    [Abstract] [Full Text] [Related]

  • 13. [Clinical implications of a new TSH receptor antibody assay (DYNOtest TRAKhuman) in autoimmune thyroid diseases].
    Meller J, Schreivogel I, Bergmann A, Morgenthaler N, Hüfner M, Becker W.
    Nuklearmedizin; 2000 Mar; 39(1):14-8. PubMed ID: 10726252
    [Abstract] [Full Text] [Related]

  • 14. Distinction between autoimmune and non-autoimmune hyperthyroidism by determination of TSH-receptor antibodies in patients with the initial diagnosis of toxic multinodular goiter.
    Wallaschofski H, Orda C, Georgi P, Miehle K, Paschke R.
    Horm Metab Res; 2001 Aug; 33(8):504-7. PubMed ID: 11544566
    [Abstract] [Full Text] [Related]

  • 15. Clinical relevance of thyroid-stimulating autoantibodies in pediatric graves' disease-a multicenter study.
    Diana T, Brown RS, Bossowski A, Segni M, Niedziela M, König J, Bossowska A, Ziora K, Hale A, Smith J, Pitz S, Kanitz M, Kahaly GJ.
    J Clin Endocrinol Metab; 2014 May; 99(5):1648-55. PubMed ID: 24517152
    [Abstract] [Full Text] [Related]

  • 16. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
    Kung AW, Lau KS, Kohn LD.
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
    [Abstract] [Full Text] [Related]

  • 17. [Measurement of thyrotropin receptor antibodies (TRAK) with a second generation assay in patients with Graves' disease].
    Zöphel K, Wunderlich G, Koch R, Franke WG.
    Nuklearmedizin; 2000 Aug; 39(4):113-20. PubMed ID: 10919162
    [Abstract] [Full Text] [Related]

  • 18. [Spontaneous hypothyroidism in 4 patients with Graves-Basedow disease].
    González-González A, Recio Cordova JM, Aznar Ondoño I, Del Monte Jarabo Bueno M.
    Endocrinol Nutr; 2009 May; 56(5):273-6. PubMed ID: 19627750
    [Abstract] [Full Text] [Related]

  • 19. Production of bioactive rabbit antibodies against the mutated receptor peptide TSH-R-HIS17 and detection of hypertriiodothyroninemia in the rabbit.
    Hirooka Y, Mitsuma T, Nogimori T, Ishizuki Y, Sakai J, Naruse M, Fukayama M.
    Biochem Mol Biol Int; 1993 Mar; 29(3):493-7. PubMed ID: 8097936
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of classification of Graves' disease according to the characteristics of TSH receptor antibodies.
    Kim WB, Chung HK, Park YJ, Park DJ, Lee HK, Cho BY.
    Korean J Intern Med; 2001 Sep; 16(3):187-200. PubMed ID: 11769578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.